BIOBETTER

In News

FAQ: Understanding Biosimilars, Biobetters, and Interchangeability - BioPharm International

BioPharm International - Dec 24, 2025

BIOBETTERS…. What’s in Your Vocabulary? - Anton Health

Anton Health - Jan 16, 2024

Biobetter Development - PharmTech.com

PharmTech.com - Jul 09, 2024

Celltrion Submits BLA for Infliximab Biobetter - Center for Biosimilars

Center for Biosimilars - Jan 05, 2023

With Its $10 Million Series A, Biobetter Brings Cultivated Meat Growth Media Down From $500,000 Per Gram to $1 - Green Queen Media

Green Queen Media - Sep 08, 2022

Next Generation of Biosimilars and Biobetters: Challenges and Opportunities - drugdiscoverytrends.com

drugdiscoverytrends.com - Oct 22, 2018

10 cultured meat companies driving sustainable food in 2025 - Labiotech.eu

Labiotech.eu - Jun 18, 2025

BioBetter wins FoodTech 2022 competition - CTech

CTech - Nov 07, 2022

Foodtech in focus: BioBetter bets on tobacco to bring down cultivated meat costs - AgFunderNews

AgFunderNews - Oct 06, 2022

Tobacco as food’s future: BioBetter creates a cell growth medium from the plant - Food Dive

Food Dive - Apr 21, 2022

Mabpharm gains approval for infliximab biobetter in China - Generics and Biosimilars Initiative

Generics and Biosimilars Initiative - Sep 10, 2021

Review: Biobetters and Biosimilars Set to Emerge in Ophthalmology - Center for Biosimilars

Center for Biosimilars - Jan 06, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment